Influence of low-intensity anticoagulation and low-dose antiplatelet agent on coagulation-fibrinolysis system after mechanical prosthetic valve replacement  by Moriyama, Yukinori et al.
right ventricle, which may result in a right-to-left inter-
atrial shunt.
Closure of the PFO is indicated to relieve the symptoms of
orthodeoxia and platypnea. Treatment options range from
open cardiac operations (most common) to conservative
methods like transcatheter closure. Cardiac surgery presents
another major surgical procedure and is contraindicated in
the presence of a BPF and empyema. Transcatheter closure
provides a minimal invasive technique to close the PFO.
BPF after pneumonectomy is one of the most formida-
ble complications in thoracic surgery. The overall inci-
dence of postresectional BPF is 1% to 5%. Endoscopic
closure with pledget and glue application improved clini-
cal health. Endoscopic closure has been shown to be
successful in 50% of patients with BPFs4 and has been
promoted as a first line of therapy.5 Bronchial stump
sealing provided stability for placement of the clamshell
device. Later, definitive drainage of the empyema was
performed by means of an Eloesser flap.
Conclusion. Synchronous PFO and BPF presents ex-
treme challenges after postpneumonectomy. A minimal
invasive approach with endoscopic control of the BPF and
transvenous closure of the PFO avoided major surgical
procedures in a patient who was in greatly compromised
condition. Permanent closure of the BPF has occurred
after thoracostoma drainage.
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INFLUENCE OF LOW-INTENSITY ANTICOAGULATION AND LOW-DOSE ANTIPLATELET AGENT
ON COAGULATION-FIBRINOLYSIS SYSTEM AFTER MECHANICAL PROSTHETIC VALVE
REPLACEMENT
Yukinori Moriyama, Kazuo Nakamura, Hiroko Kariyazono, Hitoshi Toyohira, and Akira Taira, Kagoshima City, Japan
Mechanical prosthetic heart valve replacement requires
lifelong anticoagulant therapy, although the optimal ther-
apeutic range has not been established. To date several
trials have tested the efficacy and safety of combined
anticoagulant and antiplatelet therapy for patients with
prosthetic valves.1-3 In this article we examined the influ-
ence of the combination of a less intense program of oral
anticoagulation plus low-dose antiplatelets on the coagu-
lation and fibrinolysis systems after prosthetic valve re-
placement.
Twenty-one patients underwent elective valve replace-
ment with Omnicarbon tilting disc valves (Medical Inc.,
Inver Grove Heights, Minn.) at our institution. The group
comprised 14 men and seven women aged between 27 and
69 years, with a mean age of 51 years. Operative proce-
dures were aortic valve replacement (n 5 11), mitral valve
replacement (n 5 9), and aortic plus mitral valve replace-
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Fig. 1. Chest radiograph showing shifting of the medias-
tinum into the postpneumonectomy space.
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ment (n 5 1). Five patients had atrial fibrillation and two
had a giant left atrium. However, neither heart failure nor
left atrial thrombus was found in any patient before the
operation. The dose of warfarin was started at 3 mg/day
and adjusted to control prothrombin time/international
normalized ratio at around 2.0 in combination with an
antiplatelet agent—either aspirin (81 mg/day, n 5 8) or
ticlopidine (200 mg/day, n 5 13). No drugs affecting the
blood coagulation system other than these agents were
administered. The dynamics of thrombin generation were
monitored over a 2-year period using prothrombin frag-
ment 112 (F112), thrombin-antithrombin III complex
(TAT), D-dimer, and other coagulation-related factors
such as warfarin concentration, vitamin K1–epoxide, and
protein C. Platelet function was also assessed by maximum
aggregation to adenosine diphosphate (2 mmol/L) stimu-
lation. Blood samples were taken before the operation
and 1, 6, 12, and 24 months after the operation. Nonpara-
metric data were shown as median with interquartile
range, and a multiple comparison test was performed by
means of NP Multi.
Table I demonstrated time course of warfarin dose and
blood concentrations of related factors. Before the oper-
ation, levels of F112, TAT, and D-dimer were high,
indicating enhanced thrombin production and hyperfi-
brinolysis. Despite our combined anticoagulant and anti-
platelet therapy, the levels of those parameters remained
high during the first year after the operation. However, by
the end of the second year they decreased significantly and
returned to within normal range as compared with those
in the first year. Platelet function after the operation was
suppressed to a similar degree irrespective of the anti-
platelet agent used (Table II). There were no obvious
thromboembolic or hemorrhagic complications through-
out the follow-up period.
Although many studies have been undertaken to ascer-
tain the appropriate level of anticoagulation in patients
with prosthetic valve implants, the optimal range of
anticoagulation is still controversial.1, 2 In general, throm-
boembolism is reported to occur in up to 2% of patients
per year, and the frequency of major bleeding events
ranges between 0.7% and 6.3% per patient-year.3 For the
past 10 years a total of 417 patients have undergone valve
replacement surgery with the Omnicarbon tilting disc
valve and have been placed on the same anticoagulant
therapy as described above at our institution. The total
follow-up was 1750 patient-years. The incidences of em-
bolic and hemorrhagic episodes were 0.7% and 0.6% per
patient-years, respectively. Despite the low rate of embo-
lism in our clinical experience, prosthetic valve replace-
ment induces significant activation of the coagulation and
fibrinolysis systems during the subsequent first year. How-
Table I. Anticoagulation in patients with prosthetic valve replacement (n 5 21)
Duration of warfarin treatment (postoperative months)
Before 1 6 12 24
PT-INR 0.9 6 0.1 2.0 6 0.6 1.5 6 0.4 1.6 6 0.5 1.8 6 0.5
WD (mg/day) 0 3.7 6 1.9 3.7 6 1.7 3.8 6 1.6 3.6 6 1.7
WC (ng/ml) 0 843 6 261 983 6 403 911 6 319 893 6 384
PC (%) 98 6 17 53 6 13 62 6 17 58 6 14 52 6 13
VK1-epo (ng/ml) 0 2.0 6 1.3 3.0 6 2.4 3.5 6 4.1 3.6 6 3.6
PT, Prothrombin time; INR, international normalized ratio; WD, warfarin dose; WC, warfarin concentration; PC, protein C; VK1-epo, vitamin K1-epoxide.
Values 5 mean 6 standard deviation.
Table II. Changes in F112 , TAT, and D-dimer (n 5 21)
Before
Duration of warfarin treatment (postoperative months)
1 6 12 24
F112 (nmol/L)
Median (interquartile range) 8.3 (6.3) 5.1 (3.9) 5.1 (5.1) 4.7 (5.0) 2.1 (2.4)
TAT (ng/ml)
Median (interquartile range) 6.1 (6.2) 5.6 (3.7) 5.8 (8.5) 4.5 (4.6) 2.0 (1.9)
D-dimer (mg/ml)
Median (interquartile range) 5.0 (9.6) 6.9 (11.5) 11.3 (13.5) 12.2 (11.5) 1.5 (6.4)
Platelet aggregation (%)
Median (interquartile range) 41.0 (42.5) 28.0 (11.3) 24.0 (13.8) 30.0 (16.8) 29.0 (18.8)
F112, Prothrombin fragment 1 1 2; TAT, thrombin-antithrombin III complexes. The data are shown as median. Interquartile ranges are in parentheses.
*p , 0.05.
†p , 0.01.
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ever, activation of these systems subsides by the end of the
second year, even on a program of low-intensity antico-
agulation with low-dose antiplatelet agent.
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ASSESSMENT OF LONG-TERM LEFT INTERNAL THORACIC ARTERY GRAFT PATENCY BY
EXERCISE DOPPLER ECHOCARDIOGRAPHY
Yuki Yoshida, MT,a Masatoshi Fujita, MD,b Yasuki Kihara, MD,b Shigeru Kubo, MT,a Terumitsu Tanaka, MD,c
Tomoyuki Iwase, MD,c Shun-ichi Tamaki, MD,c Tatsuro Sato, MD,d Chang-Hee Park, MD,d and
Ario Yamazato, MD,d Kyoto, Japan
Internal thoracic artery grafting is preferable to grafting
with saphenous veins because of the higher long-term
patency rate.1 Coronary arteriography is still a gold stan-
dard for left internal thoracic artery (LITA) graft patency.
However, the angiographic approach is limited in evalu-
ating physiologic response to increased myocardial oxygen
demand and in repeated investigations during the long-
term follow-up period. Doppler echocardiography is re-
ported to be a reliable method to noninvasively assess the
LITA flow pattern.2-4 However, to our best knowledge,
there is no report on LITA graft flow characteristics
during exercise. In the present study, therefore, we hy-
pothesized that Doppler echocardiography during exer-
cise would provide more precise information about pa-
tency of the LITA graft during the long follow-up period.
Methods. Among 38 consecutive cases of coronary
artery bypass grafting with the LITA to the left anterior
descending coronary artery (LAD), exercise Doppler
echocardiography was performed in 22 patients (20 men,
2 women, 60 6 7 [standard deviation] years) who had not
had a previous anterior myocardial infarction and had
90% to 100% diameter stenosis in the LAD proximal to
the anastomotic site. These patients were selected to be
studied, and after their Doppler study they all underwent
a second coronary angiography. The time interval be-
tween the operation and the Doppler study was 20.9 6 7.0
days.
Supine bicycle exercise testing was conducted at a
constant workload of 25 W until either chest pain or leg
fatigue appeared. After a 24-hour withdrawal of all med-
ications, Doppler echocardiographic studies were per-
formed with a Toshiba SSA-260A echocardiograph with a
5 MHz transducer. The transducer was positioned at the
left supraclavicular fossa, the ultrasonic beam was di-
rected toward the caudal site from the transducer, and the
LITA graft was observed on the two-dimensional echo-
cardiogram.3 The sample volume was placed on the graft,
and graft blood flow was detected by means of pulsed-
wave Doppler echocardiography. Doppler signals were
recorded for 30 seconds at rest and for 30 seconds
immediately after the cessation of exercise on a videotape
for later analysis.
On the basis of the angiographic data, 22 patients were
divided into two groups: group A, 15 patients with a
patent LITA graft (,25% diameter stenosis); group B,
seven patients with a severely stenosed LITA graft (75%
to 99% diameter stenosis) at the site of the anastomosis
with the LAD. No stenosis was found in the proximal site
of the LITA graft where flow velocities were measured.
Ten of 15 patients in group A were restudied 10 months
after the operation to evaluate the long-term LITA graft
patency.
Results. In all patients, optimal Doppler signal record-
ings were obtained at rest and during exercise. There were
no significant differences in the diastolic/systolic peak
velocity ratio and diastolic fraction of time-velocity inte-
gral at rest between groups A and B (Fig. 1). The exercise
to rest ratio of mean diastolic velocity (the index of LITA
flow reserve) was 2.03 6 0.48 in group A, being signifi-
cantly higher than 1.26 6 0.20 in group B (p , 0.01) (Fig.
2). There were no significant differences in pressure-rate
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